A group of Bristol-based entrepreneurs has invested £192,500 into a research and development project in the city that is searching for faster diagnosis and treatment of sepsis.
16 members of Bristol Private Equity Club (BPEC) have backed GenomeKey, which is carrying out the pioneering research programme.
